(70 days)
Not Found
Not Found
Based on the provided text, there is no indication that this device contains an AI model.
The text describes the intended use, indications for use, and device description of endocardial leads for use with implantable pulse generators. It focuses on the physical characteristics of the leads and their compatibility with pacing systems.
The "Mentions AI, DNN, or ML" field is explicitly marked as "Not Found", which further supports the conclusion that an AI model is not present in this device based on the provided information.
Yes
The device is described as "endocardial leads" designed for use with "implantable pulse generators" for "pacing therapy," which clearly indicates a therapeutic function.
No
The provided text describes pacing leads for implantable pulse generators, which are therapeutic devices. There is no mention of diagnostic functions.
No
The device description explicitly states it is a modification to the packaging process and containers for bradycardia pacing leads, which are hardware medical devices. There is no mention of software as the primary component or function.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use describes the device as "endocardial leads designed for use with implantable pulse generators that require pacing leads... for use in patients for whom single or dual chamber pacing therapy is medically indicated." This clearly indicates a device used within the body for therapeutic purposes (pacing the heart).
- Device Description: The description talks about "bradycardia pacing leads" and modifications to their "packaging process and containers." This further reinforces that it's an implantable device.
- Lack of IVD Indicators: The text does not mention anything about:
- Analyzing samples taken from the human body (blood, urine, tissue, etc.).
- Providing information for diagnosis, monitoring, or screening based on in vitro examination of these samples.
IVD devices are specifically designed to perform tests on samples outside of the body to provide diagnostic information. This device is an implantable medical device used for treatment.
N/A
Intended Use / Indications for Use
BIOTRONIK's endocardial leads are designed for use with implantable pulse generators that require pacing leads with a bipolar IS-1 connector configuration; they may be used with single or dual chamber pacing systems. The leads are designed for use in patients for whom single or dual chamber pulse generator therapy is medically indicated. This indication follows that recommended in the Class t definition of the ACC/AHA/NASPE Task Force Report, entitled "ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation)" (Gregoratos et al. 2002).
The straight lead models are intended for placement in either the right atrium or right ventricle. The JBP lead models have a pre-formed J-shaped distal end to facilitate lead placement in the right atrial appendage.
Product codes
DTB
Device Description
BIOTRONIK proposes modifications to the packaging process and containers for bradycardia pacing leads, at BIOTRONIK's manufacturing and sterilization facility (BIOTRONIK GmbH & Co. KG) in Pertin, Germany and contract manufacturing facility (BIOTRONIK AG) in Bülach Switzerland.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
right atrium or right ventricle, right atrial appendage
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Not Found
Key Metrics
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.3680 Cardiovascular permanent or temporary pacemaker electrode.
(a)
Temporary pacemaker electrode —(1)Identification. A temporary pacemaker electrode is a device consisting of flexible insulated electrical conductors with one end connected to anexternal pacemaker pulse generator and the other end applied to the heart. The device is used to transmit a pacing electrical stimulus from the pulse generator to the heart and/or to transmit the electrical signal of the heart to the pulse generator.(2)
Classification. Class II (performance standards).(b)
Permanent pacemaker electrode —(1)Identification. A permanent pacemaker electrode is a device consisting of flexible insulated electrical conductors with one end connected to an implantable pacemaker pulse generator and the other end applied to the heart. The device is used to transmit a pacing electrical stimulus from the pulse generator to the heart and/or to transmit the electrical signal of the heart to the pulse generator.(2)
Classification. Class III (premarket approval).(c)
Date PMA or notice of completion of PDP is required. A PMA or notice of completion of a PDP is required to be filed with the Food and Drug Administration on or before October 4, 2012, for any permanent pacemaker electrode device that was in commercial distribution before May 28, 1976, or that has, on or before October 4, 2012, been found to be substantially equivalent to any permanent pacemaker electrode device that was in commercial distribution before May 28, 1976. Any other pacemaker repair or replacement material device shall have an approved PMA or declared completed PDP in effect before being placed in commercial distribution.
0
Ko61212
April 28, 2006
Packaging Changes for Endocardial Pacing Leads
Special 510(k) Premarket Notification
1. 510(k) SUMMARY
Name and Address of Sponsor:
BIOTRONIK, Inc. 6024 Jean Road Lake Oswego, OR 97035 JUL 1 0 2000
Establishment Registration Number:
1028232
Device Name:
| Product | Proprietary Name (Multiple) | FDA Product Code | Classification Name | Device Classification |
|---|---|---|---|---|
| Arox | Arox 53-BP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| Arox 60-BP | ||||
| Arox 45-JBP | ||||
| Arox 53-JBP | ||||
| Synox | Synox-SX 45-JBP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| Synox-SX 53-JBP | ||||
| Synox SX 53-BP | ||||
| Synox SX 60-BP | ||||
| Synox with 15 mm tip | ||||
| to ring spacing | Synox SX 53/15-BP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| Synox SX 60/15-BP | ||||
| Polyrox w/ 15 mm | ||||
| Spacing | PX 53/15-BP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| PX 60/15-BP | ||||
| Polyrox | PX 45-JBP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| PX 53-BP | ||||
| PX 53-JBP | ||||
| PX 60-BP | ||||
| YP | YP 45/15-BP | DTB | Electrode, | |
| Pacemaker, | ||||
| Permanent | III (21 CFR | |||
| 870.3680) | ||||
| YP 53/15-BP | ||||
| YP 60/15-BP |
General Description and Predicate Devices:
BIOTRONIK proposes modifications to the packaging process and containers for bradycardia pacing leads, at BIOTRONIK's manufacturing and sterilization facility (BIOTRONIK GmbH & Co. KG) in Pertin, Germany and contract manufacturing facility (BIOTRONIK AG) in Bülach Switzerland. BIOTRONIK believes that the previously approved products cleared through 510(k) notifications and manufactured and sterilized at BIOTRONIK GmbH & Co. KG in Berlin, Germany or BIOTRONIK AG in Bulach Switzerland are appropriate as predicate devices for the products affected by the aforementionaed packaging modifications. The above table provides a list of the products that are manufacturned nad/or sterlized at BIOTRONIK GmbH & Co. KG in Berlin, Germany or BIOTRONIK & G in Billadoh Switzrdand and the 510(k) notifications under which the products were cleared.
1
Indication for Use:
BIOTRONIK's endocardial leads are designed for use with implantable pulse generators that require pacing leads with a bipolar IS-1 connector configuration; they may be used with single or dual chamber pacing systems. The leads are designed for use in patients for whom single or dual chamber pulse generator therapy is medically indicated. This indication follows that recommended in the Class t definition of the ACC/AHA/NASPE Task Force Report, entitled "ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee on Pacemaker Implantation)" (Gregoratos et al. 2002).
The straight lead models are intended for placement in either the right atrium or right ventricle. The JBP lead models have a pre-formed J-shaped distal end to facilitate lead placement in the right atrial appendage.
| Name and Address of Manufacturer: | BIOTRONIK GmbH & Co. KG (reg. no. 9610139)
Woermannkehre 1,
12359 Berlin, Germany
011-49-30-689-05-1210 |
|--------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------|
| Name and Address of Contract Manufacturer: | BIOTRONIK AG (reg. no. 8043892)
Ackerstrasse 6
8180 Bülach,
Switzerland 011-41-44-864-5169 |
| Contact Person(s) and Phone Number: | Jon Brumbaugh
Director, Regulatory Affairs and Compliance
Phone (888) 345-0374
Fax (503) 635-9936
jon.brumbaugh@biotronik.com |
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized caduceus symbol, which is often associated with medicine and healthcare. The words "DEPARTMENT OF HEALTH AND HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus symbol. The logo is black and white.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUL 1 0 2006
Biotronik, Inc. C/O Jon Brumbaugh 6024 Jean Rd. Lake Oswego, OR 97035
Re: K061212
Trade/Device Name: Biotronik Endocardial Pacing Leads Regulation Number: 21 CFR 870.3680 Regulation Name: Cardiovascular permanent or temporary pacemaker electrode. Regulatory Class: Class III Product Code: DTB Dated: June 21, 2006 Received: June 22, 2006
Dear Mr. Brumbaugh:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Page 2 - Mr. Jon Brumbaugh
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrl/industry/support/index.html.
Sincerely vours.
Ashley B. Bvan
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name: Bradycardia Pacing Leads, (see attached list)
Indications for Use:
Pacing Leads -
BIOTRONIK's endocardial leads are designed for use with implantable pulse generators that require pacing leads with a bipolar IS-1 connector configuration they may be used with single or dual chamber pacing systems. The leads are designed for use in patients for whom single or dual chamber pasing of pasing therapy is medically indicated. This indication for them single of the Class I definition of the ACC/AHANASPE This Indication This Indication inal recommended in Title Class I demind of the of Cardiac Pacemakers Reports, Aladoa Aloon More 2 2002 Ghuelle Opdate of Inplantabon
CordialemyAmadon Mond Anad Anada Arabarhythmia Devices: A Report of the American Colleg CardiologyAmerican Heart Association Task Force on Practice Guidelines (ACCAHANASPE Committee on Pacemaker Implantation)" (Gregoratos et al. 2002).
The straight lead models are intended for placement in either the right atrium or right ventricle. The JBP lead models have a pre-formed distal end to facilitate lead placement in the ight atrial appendage.
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Arilla B. Beane
510(k) Number LC61212
Page 1 of 2